The brand, developed by MOYOM Biotech, utilized the event to showcase its MagiCCrystal CaHA Biostructurer. Designed for anatomy-based contouring of the brow, nose, chin, and jawline, the product aims to enhance structural definition while preserving individual facial character. The presence of Zhang Xue, founder of the motorcycle brand ZXMOTO, underscored the crossover between precision engineering in motorsports and the firm's approach to medical aesthetics.
aphranel® Targets Male Aesthetics at MXGP Shanghai 2026
Amidst the high-octane atmosphere of the 2026 FIM Motocross World Championship in Shanghai, Chinese regenerative aesthetics brand aphranel® pivoted toward an unexpected demographic. By installing a high-design exhibition space at the race, the company sought to introduce its technical facial contouring solutions to a predominantly male audience.
Technically, the product represents over a decade of research. Following a development program initiated in 2013 and supported by China’s National Science and Technology Major Project, MagiCCrystal secured NMPA Class III medical device registration in February 2025. It stands as the first calcium hydroxylapatite microsphere biostructurer approved in the country. Since its launch, the company reports over 200,000 syringes sold across 700 clinics. By aligning its brand identity with the endurance and technical rigor of professional racing, aphranel® is positioning its domestic biomaterial technology for a wider international market.
Comments (0)
No comments yet. Be the first!